ORGO 3.97 (-2.7%)
US68621F1021Drug ManufacturersDrug Manufacturers - Specialty & Generic

Organogenesis Holdings (ORGO) Stock Highlights

3.97 | -2.7%
2024-11-21 04:44:41
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Statistics

Range Today
3.9 4.16
Volume Today 763.6K
Range 1 Year
2.16 4.7
Volume 1 Year 209.82M
Range 3 Year
1.79 10.66
Volume 3 Year 711.69M
Range 10 Year
1.79 310.9
Volume 10 Year 1.05B

Highlights

Market Capitalization 434.85M (small)
Floating Shares 59.76M
Current Price 3.97
Price To Earnings -27.42
Price To Revenue 1.02
Price To Book 1.65
Earnings Per Share -0.12
Payout Ratio 0%

Performance

Latest -2.7%
1 Month +26.43%
3 Months +48.69%
6 Months +44.36%
1 Year +49.81%
3 Years -60.69%
5 Years -48.58%
10 Years -59.7%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.